Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study

Boswood, A and Gordon, S G and Häggström, J and Vanselow, M and Wess, G and Stepien, R L and Oyama, M A and Keene, B W and Bonagura, J and MacDonald, K A and Patteson, M and Smith, S and Fox, P R and Sanderson, K and Woolley, R and Szatmári, V and Menaut, P and Church, W M and O'Sullivan, M L and Jaudon, J-P and Kresken, J-G and Rush, J and Barrett, K A and Rosenthal, S L and Saunders, A B and Ljungvall, I and Deinert, M and Bomassi, E and Estrada, A H and Fernández-Del Palacio, M J and Moise, N S and Abbott, J A and Fujii, Y and Spier, A and Luethy, M W and Santilli, R A and Uechi, M and Tidholm, A and Schummer, C and Watson, P (2020) Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study. JOURNAL OF VETERINARY INTERNAL MEDICINE. ISSN 1939-1676

[img]
Preview
Text
12608_Temporal-changes-in-clinical-and-radiographic-variables-in-dogs-with-preclinical-myxomatous-mitral-valve-disease-The-EPIC-study.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview
Official URL: https://doi.org/10.1111/jvim.15753

Abstract

The Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical myxomatous mitral valve disease (EPIC) study monitored dogs with myxomatous mitral valve disease (MMVD) as they developed congestive heart failure (CHF).

Actions (Repository Editors)

Edit Item Edit Item